These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Results of treating lymphomas with high degree of malignancy using COPP, CHOP-Bleo and MEV protocols]. Płuzańska A; Krykowski E; Robak T; Oliskiewicz W; Polkowska E; Dowgier I; Hyjek E Pol Tyg Lek; 1982 Sep; 37(36):1049-53. PubMed ID: 6189105 [No Abstract] [Full Text] [Related]
3. Infusions, age, and drug doses: redux. Coleman M; Boyd DB J Clin Oncol; 1988 Apr; 6(4):751. PubMed ID: 2451714 [No Abstract] [Full Text] [Related]
4. [Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy]. Sampi K; Honda T; Hattori M Rinsho Hoshasen; 1983 Jun; 28(6):673-7. PubMed ID: 6688641 [No Abstract] [Full Text] [Related]
5. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma]. Kamieńska E Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116 [TBL] [Abstract][Full Text] [Related]
6. [Exchange transfusion and combination chemotherapy in the treatment of 4 cases of childhood malignant histiocytosis]. Kizaki Z; Fukumochi H; Sawai T; Ishimura K; Esumi N; Nagai T; Todo S; Imashuku S Rinsho Ketsueki; 1987 Jun; 28(6):845-51. PubMed ID: 3669324 [No Abstract] [Full Text] [Related]
7. [Treatment of primary mediastinal large B-cell lymphomas]. Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753 [TBL] [Abstract][Full Text] [Related]
8. [Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone]. Abdyldaev RA; Kruglova GV Vopr Onkol; 1983; 29(4):83-5. PubMed ID: 6687966 [TBL] [Abstract][Full Text] [Related]
9. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group. Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065 [No Abstract] [Full Text] [Related]
10. [Malignant lymphoma of the skin]. Nakajima H; Miyamoto H Gan To Kagaku Ryoho; 1985 Sep; 12(9):1735-43. PubMed ID: 3876074 [TBL] [Abstract][Full Text] [Related]
11. [Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease]. Kumagai K; Takagi T; Sakai C; Wakatsuki S Gan To Kagaku Ryoho; 1996 Mar; 23(4):499-501. PubMed ID: 8678506 [No Abstract] [Full Text] [Related]
12. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma. Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536 [TBL] [Abstract][Full Text] [Related]
13. [Pregnancy following chemotherapy of non-Hodgkin lymphoma]. Asada E; Koide M; Kato H; Kobayashi I; Hasegawa G Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1158-61. PubMed ID: 3755741 [No Abstract] [Full Text] [Related]
14. [Lymphoma in the elderly]. Coiffier B Bull Cancer Radiother; 1996; 83(4):265-8. PubMed ID: 9081325 [No Abstract] [Full Text] [Related]
15. Malignant histiocytosis: therapeutic results in 27 children treated with a single polychemotherapy regimen. Brugieres L; Caillaud JM; Patte C; Rodary C; Bernard A; Kalifa C; Hartmann O; Lemerle J Med Pediatr Oncol; 1989; 17(3):193-6. PubMed ID: 2747592 [TBL] [Abstract][Full Text] [Related]
16. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249 [TBL] [Abstract][Full Text] [Related]
17. Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas. Gerhartz HH; Engelhard M; Brittinger G; Schlimok G; Thiel E; Huber C; Emmerich B; Schadek C; Brandmaier R; Stern AC Semin Oncol; 1994 Dec; 21(6 Suppl 16):25-8. PubMed ID: 7528447 [No Abstract] [Full Text] [Related]
18. [Prognostic factors of follicular lymphoma treated with combination chemotherapy]. Niitsu N; Umeda M Rinsho Ketsueki; 1997 Jun; 38(6):496-504. PubMed ID: 9248325 [TBL] [Abstract][Full Text] [Related]
19. Primary malignant lymphoma of the uterine cervix shows favorable response to neoadjuvant chemotherapy. Kuo HC; Chou CY; Chang CH; Liu MT; Tzeng CC; Huang KE Gynecol Oncol; 1994 Mar; 52(3):408-10. PubMed ID: 7512523 [TBL] [Abstract][Full Text] [Related]
20. Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up. Björkholm M; Celsing F; Johansson E; Ann Hematol; 2006 Oct; 85(10):731-3. PubMed ID: 16838163 [No Abstract] [Full Text] [Related] [Next] [New Search]